SCHEMBL24315949

SCHEMBL24315949

CNC(=O)CCC(C=O)N1C(=O)c2ccc(C3(F)CCN(C)CC3)c3cccc1c23

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316240 0.79 CYP1B1 (0.41) KDM4E
SCHEMBL24315752 0.79 HDAC8 (0.40) KDM4E
SCHEMBL24315912 0.77 KDM4E (0.34) KDM4E
SCHEMBL24316089 0.74 MAPT (0.41)
SCHEMBL24315846 0.71 LMNA (0.39)
SCHEMBL24317766 0.70 MAPT (0.34) KDM4E
SCHEMBL23267574 0.70 MAPT (0.35)
SCHEMBL24317938 0.69 ALDH1A1 (0.39) KDM4E
SCHEMBL24317937 0.67 KMT2A (0.41)
SCHEMBL22550089 0.66 KMT2A (0.35) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed